CD56 negative NK cells: origin, function, and role in chronic viral disease
about
The role of NK cells in HIV-1 protection: autologous, allogeneic or both?Human NK cell development requires CD56-mediated motility and formation of the developmental synapse.Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell SubsetsFeatures of Memory-Like and PD-1(+) Human NK Cell SubsetsChanges in cytokine levels and NK cell activation associated with influenza.Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.Hepatitis C Virus and Human Cytomegalovirus-Natural Killer Cell Subsets in Persistent Viral Infections.Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis.Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcomaCXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.Increased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes.Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progressionTim-3 expression defines regulatory T cells in human tumors.NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infectionHealthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral ActivityElevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.Persistence of pathological distribution of NK cells in HIV-infected patients with prolonged use of HAART and a sustained immune responseEffects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infectionHIV-1 Vpu interference with innate cell-mediated immune mechanisms.Alterations of the NK cell pool in HIV/HCV co-infectionLymphocyte subpopulations in myocardial infarction: a comparison between peripheral and intracoronary blood.NK cells in healthy aging and age-associated diseasesThe impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life.Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections.IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo.Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.Changes in cellular proliferation and plasma products are associated with liver failure.Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections.Natural Killer Cell Development and Maturation Revisited: Possible Implications of a Novel Distinct Lin-CD34+DNAM-1brightCXCR4+ Cell Progenitor.Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection.Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands.NK cells and their receptors during viral infections.NK cells prevalence, subsets and function in viral hepatitis C.Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.Impact of HCMV Infection on NK Cell Development and Function after HSCT.NK Cell Subset Redistribution during the Course of Viral Infections.Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis.
P2860
Q26753146-DD9ACB4B-7731-4B49-B256-3E37AEEF730EQ27335804-82E8461C-46A0-424A-8071-EE97AC59EAE6Q28067993-58180F71-6303-4DFD-A26E-73C1F3EBDB48Q28073988-C9ECFB1D-2358-4533-82C5-D6376FCA5BD7Q30407695-919DBB4C-AE2D-4A62-BB71-FDD1AC0A9093Q33572705-D0FA2CF1-BDEC-43D6-B181-0CB09C04F7E7Q33654658-2D3A9C0F-3BFC-4117-AA1A-54F022DF838BQ33694920-4F1E32EB-96D3-4EDA-8002-F94F3CE0D782Q33745372-99374538-48B3-413B-B99E-006BA4EDF4A1Q34130226-1D955E7E-87FA-4860-83AD-E1C0BE189AF4Q34323663-CA343D52-BFCF-4E43-BD77-D1438BEB8D2CQ34339253-7E7D1368-DF90-491B-8D46-E6850CC0B75AQ34501427-CD607FFF-01CC-40DF-981D-1F6F140A5C25Q34512559-1797E0E9-2E19-4190-8C1F-77A5B9FF81EFQ34593740-0F834A78-EA26-441E-91AA-981EFE8ECA9DQ34634058-B4D74C07-1FF6-4BEB-9BB1-6DD29A23C955Q34680046-FD75D470-FFD6-417D-BF83-402CC15CB629Q34785742-A69A4C85-397E-4210-AB7B-F63EF78BE446Q35096435-39C77744-4660-4763-AE1F-520DF6543074Q35219896-AB78DC41-68DA-4EC4-83C9-086A8FA20715Q35731394-9C446E87-9BC3-4330-8BBC-53D11DA23BA1Q36141355-D6625217-7670-4D59-8A9E-3D4DB46F654CQ36336081-3BB46563-0CAA-4AD4-944D-205065CC35B3Q36339037-F5860123-30FB-4BF2-B507-C1E6D7C7B314Q36453421-D55A9BDE-7A9E-481D-83CB-5489A4402251Q36496904-40847A8D-DD53-49E7-BDBC-32DFAE2CDE03Q37048079-12E95D28-6BCA-4523-8924-143501760949Q37141296-569BABF5-CA18-4605-A247-8051AE6D0CCAQ37178190-8475ACE3-15AB-4C1B-81E5-C90FB9145B02Q37421478-9E493680-03AD-4562-A49C-E3F18F0C501EQ37634627-1CF021AE-0A76-4F0D-BB0A-42D9E24709CFQ37689426-F1306644-CE65-421D-B63B-A16FCACEF6AAQ37862747-7DBE1749-0119-484A-906D-046531AF8FF1Q37885284-5223B2A7-04F7-4818-88E8-4DFF54A55FA0Q37931256-BFF9114E-A3BD-4D81-8156-D84BFCA6E442Q37942504-68D51C5B-0B52-49D4-9BC9-DE1EA24558A0Q38095771-5820A2D0-6EF7-46CB-9A40-C9FBEE083DA0Q38174881-E54B5624-7FFB-4080-831F-2EC032D4301AQ38245228-CC91E2AF-8342-44F8-9FC8-E537C03B0CF1Q38457805-1B520DC6-1D8F-489F-BE31-B0D1966F4F92
P2860
CD56 negative NK cells: origin, function, and role in chronic viral disease
description
im September 2010 veröffentlicher wissenschaftlicher Artikel
@de
scientific article published on 07 September 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2010
@uk
name
CD56 negative NK cells: origin, function, and role in chronic viral disease
@en
CD56 negative NK cells: origin, function, and role in chronic viral disease
@nl
type
label
CD56 negative NK cells: origin, function, and role in chronic viral disease
@en
CD56 negative NK cells: origin, function, and role in chronic viral disease
@nl
prefLabel
CD56 negative NK cells: origin, function, and role in chronic viral disease
@en
CD56 negative NK cells: origin, function, and role in chronic viral disease
@nl
P356
P1433
P1476
CD56 negative NK cells: origin, function, and role in chronic viral disease
@en
P2093
Hans-Gustaf Ljunggren
P304
P356
10.1016/J.IT.2010.08.003
P577
2010-09-07T00:00:00Z